IMA vs WELL · rev $9.2M vs P/E 100, rev $10.84B
ImageneBio, Inc. (IMA) versus Welltower Inc (WELL) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Welltower Inc (WELL) is a reit - healthcare facilities company listed on NYSE.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported WELL revenue for 2025-12-31 was $10.84B. Net income was $936.8M. Revenue was up 35.6% from 2024-12-31 to 2025-12-31. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
IMA currently screens at market cap $64.7M. WELL currently screens at market cap $145.81B and trailing P/E 99.8.
Not investment advice. Open the IMA and WELL stock pages for the full models.
Not investment advice.